Response to Platinum-Based Chemotherapy Predicts Survival in Lung Cancer Patients. Prospective Analysis of 340 Patients.

被引：0
|
作者：
Duarte, R. L. M.
Paschoal, M. E. M.
机构：
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2009年 / 179卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A4440
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Fluoropyrimidine/platinum-based first-line chemotherapy in metastatic esophageal squamous cell carcinoma: Prognostic factor analysis in 239 patients.
    Jung, H. A.
    Lee, J.
    Ahn, H. K.
    Park, S. H.
    Park, Y. H.
    Im, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [42] Genetic variations predicting cisplatin cytotoxicity associated with the overall survival in lung cancer patients receiving platinum-based chemotherapy
    Tan, Xiang-Lin
    Moyer, Ann M.
    Schaid, Daniel J.
    Niu, Nifang
    Batzler, Anthony
    Li, Liang
    Sun, Zhifu
    Yang, Ping
    Wang, Liewei
    CANCER RESEARCH, 2011, 71
  • [43] Genetic Variation Predicting Cisplatin Cytotoxicity Associated with Overall Survival in Lung Cancer Patients Receiving Platinum-Based Chemotherapy
    Tan, Xiang-Lin
    Moyer, Ann M.
    Fridley, Brooke L.
    Schaid, Daniel J.
    Niu, Nifang
    Batzler, Anthony J.
    Jenkins, Gregory D.
    Abo, Ryan P.
    Li, Liang
    Cunningham, Julie M.
    Sun, Zhifu
    Yang, Ping
    Wang, Liewei
    CLINICAL CANCER RESEARCH, 2011, 17 (17) : 5801 - 5811
  • [44] Cellular immunotherapy combined with platinum-based chemotherapy prolongs survival for non-small cell lung cancer patients
    Qian, Lei
    Ding, Xiao
    Li, Fang-Qi
    Tian, Hui-Min
    Chen, Xiao
    Han, Fu-Jun
    Wang, Hong-Yi
    Li, Wen-Qian
    Niu, Chao
    Xu, Jian-Ting
    Li, Zhao-Zhi
    He, Hua
    Cui, Jiu-Wei
    NEOPLASMA, 2023, 70 (02) : 251 - 259
  • [45] EGFR mutation and response to chemotherapy in non-small-cell lung cancer (NSCLC) patients.
    Lee, KH
    Han, SW
    Jeong, S
    Kim, DW
    Chung, DH
    Im, SA
    Kim, TY
    Heo, DS
    Bang, YJ
    Kim, NK
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 641S - 641S
  • [46] Criterion validity of Medicare chemotherapy claims in breast and lung cancer patients.
    Lamont, EB
    Herndon, JE
    Weeks, JC
    Henderson, IC
    Lilenbaum, R
    Schilsky, RL
    Christakis, NA
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 533S - 533S
  • [47] The A/G allele of eIF3a rs3740556 predicts platinum-based chemotherapy resistance in lung cancer patients
    Xu, Xiaojing
    Han, Lifang
    Yang, Huaping
    Duan, Li
    Zhou, Boting
    Zhao, Yingchun
    Qu, Jian
    Ma, Rui
    Zhou, Honghao
    Liu, Zhaoqian
    LUNG CANCER, 2013, 79 (01) : 65 - 72
  • [48] NANOG Predicts Poor Outcome in Advanced Non-Small Cell Lung Cancer Patients Treated with Platinum-Based Chemotherapy
    Lee, Seung Hyeun
    Park, Myung Jae
    Park, So Young
    In, Kwang Ho
    Kim, Chul Hwan
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S959 - S960
  • [49] Lung cancer screening in COPD patients.
    Pascarella, Maria
    Schumann, Desiree
    Stalder-Siebeneichler, Aline
    Papakonstantinou, Eleni
    Giroy, Corinne
    Oertli, Nora
    Tamm, Michael
    Stolz, Daiana
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [50] MMR deficiency of lung cancer patients.
    Ming, Zongjuan
    Yang, Shuanying
    Shi, Jie
    Bai, Jun
    Wei, Xuemei
    Lu, Qiang
    Li, Wei
    Zhong, Yujie
    Yang, Xia
    Lyu, Xin
    Wei, Qingbo
    Gu, Dejian
    Chen, Rongrong
    Yuan, Jingyan
    Chen, Yang
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345